Risks and prevention of nosocomial transmission of rare zoonotic diseases

Clinical Infectious Diseases

Volumn 32, Issue 3, 2001, Pages 446-456

  Weber, D J ^a   Rutala, W A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMOXICILLIN; ANTIBODY; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; PENICILLIN G; RIBAVIRIN; STREPTOMYCIN; TETRACYCLINE; VACCINE;

ANTHRAX; COXIELLA BURNETII; EBOLA VIRUS; HEMORRHAGIC FEVER; HERPES VIRUS; HOSPITAL INFECTION; HUMAN; LASSA VIRUS; MARBURG VIRUS; MASK; NAIRO VIRUS; ORTHOPOXVIRUS; PATIENT CARE; PLAGUE; POXVIRUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; Q FEVER; RABIES; REVIEW; RISK; VIRUS INFECTION;

ANIMALS; BIOLOGICAL WARFARE; BIOTERRORISM; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; CROSS INFECTION; HUMANS; PATIENT ISOLATION; PRACTICE GUIDELINES; RISK FACTORS; ZOONOSES;

EID: 0035115902     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318509     Document Type: Review

References (70)

1. Human salmonellosis associated with exotic pets
2. Epidemiologists and public health veterinarians issue statement on ferrets
3. B-virus from pet macaque monkeys: An emerging threat in the United States?
4. Biological and chemical terrorism: Strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup
5. Clinical recognition and management of patients exposed to biological warfare agents
6. The looming threat of bioterrorism
7. A large community outbreak of salmonellosis caused by intentional contamination of restaurant salad bars
8. An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination
9. Anthrax as a biological weapon
10. Smallpox as a biological weapon
11. Plague as a biological weapon
12. Guideline for isolation precautions in hospitals
13. The dividends of universal precautions: Absence of significant exposure to unsuspected rabies
14. Anthrax vaccine: Evidence for safety and efficacy against inhalational anthrax
15. Vaccinia (smallpox) vaccine recommendations of the Immunization Practices Advisory Committee (ACIP)
16. Prevention of plague: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
17. Human rabies prevention - United States, 1999: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
18. Miscellaneous limited-use vaccine
19. Hantavirus infections
20. Hantavirus pulmonary syndrome in the Americas
21. Hantavirus transmission in the United States
22. Evidence against person-toperson transmission of hantavirus to health care workers
23. Hantavirus pulmonary syndrome in Argentina: Possibility of person-to-person transmission
24. An unusual hantavirus outbreak in southern Argentina: Person-to-person transmission
25. Hantavirus pulmonary syndrome outbreak in Argentina: Molecular evidence for person-to-person transmission of Andes virus
26. Bioterrorism alleging use of anthrax and interim guidelines for management - United States, 1998
27. Anthrax
28. Inhalation anthrax: Epidemiology, diagnosis, and management
29. Anthrax
30. Outbreak of human anthrax in Ramabhadrapuram village of Chittoor district in Andhra Pradesh
31. Outbreak of anthrax in Thailand
32. Human anthrax in Zimbabwe
33. Anthrax in the Gambia: An epidemiological study
34. Anthrax: Clinical features, pathogenesis, and potential biological warfare threat
35. B virus, Herpesvirus simiae historical perspective
36. Biology of B virus in macaque and human hosts: A review
37. Guidelines for the prevention and treatment of B virus infections in exposed persons
38. A controlled seroprevalence survey of primate handlers for evidence of asymptomatic herpes B virus infection
39. B virus (Herpesvirus simiae) infection in humans: Epidemiologic investigation of a cluster
40. Centers for Disease Control Guidelines for prevention of Herpesvirus simiae (B virus) infection in monkey handlers
41. Herpesvirus simiae contamination of primary rhesus monkey kidney cell cultures: CDC recommendations to minimize risks to laboratory personnel
42. Hemorrhagic fevers: How they wax and wane
43. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995
44. Outbreak of Marburg virus disease in Johannesburg
45. Review of cases of nosocomial Lassa fever in Nigeria: The high price of poor medical practice
46. Nosocomial outbreak of viral hemorrhagic fever caused by Crimean hemorrhagic fever-Congo virus in Pakistan, January 1976
47. Hemorrhagic fever in Cochabamba, Bolivia, 1971
48. Epidemiology of hemorrhagic fever viruses
49. Update: Management of patients with suspected viral hemorrhagic fever - United States
50. Lassa fever epidemiological aspects of the 1970 epidemic, Jos, Nigeria
51. Management of patients with suspected viral hemorrhagic fever
52. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers
53. Human monkeypox: Clinical features of 282 patients
54. Stochastic model for interhuman spread of monkeypox
55. Plague pneumonia disease caused by Yersinia pestis
56. Recommendations for the control of Yersinia pestis infections
57. Q fever
58. Q fever in pregnancy
59. Rabies
60. New aspects of rabies with emphasis on epidemiology, diagnosis, and prevention of the disease in the United States
61. The reemergence of rabies
62. Epidemiology of human rabies in the United States, 1980-1996
63. Possible human-to-human transmission of rabies in Ethiopia
64. Is there a risk to contacts of patients with rabies?
65. Nosocomial zoonoses